↑ 薬物リストへ　← 戻る

Monarsen    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
11重症筋無力症1

11. 重症筋無力症　［臨床試験数：226，薬物数：172（DrugBank：45），標的遺伝子数：43，標的パスウェイ数：118］
Searched query = "Myasthenia", "MG"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 226 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2005-002740-26-GB
(EUCTR)		21/02/200601/12/2005A Phase II Double Blind, Cross-Over Study to Compare the Safety and Efficacy of 10, 20 and 40 mg Monarsen (EN101) administered to Patients with Myasthenia GravisA Phase II Double Blind, Cross-Over Study to Compare the Safety and Efficacy of 10, 20 and 40 mg Monarsen (EN101) administered to Patients with Myasthenia Gravis Myasthenia Gravis
MedDRA version: 8.1;Level: LLT;Classification code 10028417;Term: Myasthenia gravis 		Ester Neuroscience LtdNULLNot Recruiting Female: yes
Male: yes		30Phase 2United Kingdom